Diploma PLC (LON:DPLM - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 4,338.92 ($58.53) and traded as high as GBX 4,942 ($66.67). Diploma shares last traded at GBX 4,942 ($66.67), with a volume of 179,929 shares changing hands.
Diploma Trading Down 0.7%
The business's 50-day moving average price is GBX 4,637.05 and its two-hundred day moving average price is GBX 4,343.17. The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The firm has a market cap of £6.55 billion, a price-to-earnings ratio of 56.42, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75.
Diploma (LON:DPLM - Get Free Report) last posted its quarterly earnings data on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) earnings per share for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. Equities analysts expect that Diploma PLC will post 163.7995512 earnings per share for the current year.
Insider Buying and Selling at Diploma
In related news, insider Katie Bickerstaffe bought 44 shares of the stock in a transaction that occurred on Wednesday, May 21st. The stock was purchased at an average cost of GBX 4,867 ($65.65) per share, for a total transaction of £2,141.48 ($2,888.82). Insiders have purchased a total of 96 shares of company stock valued at $473,173 over the last ninety days. Insiders own 0.52% of the company's stock.
Diploma Company Profile
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
